NO166529C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater.Info
- Publication number
- NO166529C NO166529C NO853069A NO853069A NO166529C NO 166529 C NO166529 C NO 166529C NO 853069 A NO853069 A NO 853069A NO 853069 A NO853069 A NO 853069A NO 166529 C NO166529 C NO 166529C
- Authority
- NO
- Norway
- Prior art keywords
- pyrolide
- indion
- derivatives
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Photolithography (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Lubricants (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Suspension Of Electric Lines Or Cables (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/637,633 US4554353A (en) | 1984-08-03 | 1984-08-03 | 2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO853069L NO853069L (no) | 1986-02-04 |
| NO166529B NO166529B (no) | 1991-04-29 |
| NO166529C true NO166529C (no) | 1991-08-07 |
Family
ID=24556766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO853069A NO166529C (no) | 1984-08-03 | 1985-08-02 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4554353A (no) |
| EP (1) | EP0170281B1 (no) |
| JP (1) | JPS6143164A (no) |
| AT (1) | ATE53575T1 (no) |
| AU (1) | AU581914B2 (no) |
| CA (1) | CA1270833C (no) |
| DE (1) | DE3578172D1 (no) |
| DK (1) | DK163661C (no) |
| ES (1) | ES8703421A1 (no) |
| FI (1) | FI80876C (no) |
| GR (1) | GR851890B (no) |
| IE (1) | IE60110B1 (no) |
| IL (1) | IL75985A (no) |
| NO (1) | NO166529C (no) |
| NZ (1) | NZ212955A (no) |
| PH (1) | PH20948A (no) |
| PT (1) | PT80905B (no) |
| ZA (1) | ZA855860B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD973876S1 (en) * | 2020-03-18 | 2022-12-27 | Stephen A. Young | Blood sampling device |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2666060A (en) * | 1951-09-11 | 1954-01-12 | Ciba Pharm Prod Inc | 1, 3-bisaminoalkyl-3-phenyl-2, 5-dioxopyrrolidines |
| CH306905A (de) * | 1951-09-11 | 1955-04-30 | Ciba Geigy | Verfahren zur Herstellung eines neuen Dioxopyrrolidins. |
| FR1079802A (fr) * | 1952-02-26 | 1954-12-02 | Parke Davis & Co | Fabrication de dérivés de la succinimide |
-
1984
- 1984-08-03 US US06/637,633 patent/US4554353A/en not_active Expired - Fee Related
-
1985
- 1985-08-01 AT AT85109680T patent/ATE53575T1/de active
- 1985-08-01 GR GR851890A patent/GR851890B/el unknown
- 1985-08-01 IL IL75985A patent/IL75985A/xx not_active IP Right Cessation
- 1985-08-01 NZ NZ212955A patent/NZ212955A/en unknown
- 1985-08-01 PH PH32590A patent/PH20948A/en unknown
- 1985-08-01 DE DE8585109680T patent/DE3578172D1/de not_active Expired - Fee Related
- 1985-08-01 CA CA487944A patent/CA1270833C/en not_active Expired
- 1985-08-01 EP EP85109680A patent/EP0170281B1/en not_active Expired - Lifetime
- 1985-08-01 AU AU45693/85A patent/AU581914B2/en not_active Ceased
- 1985-08-02 IE IE193285A patent/IE60110B1/en not_active IP Right Cessation
- 1985-08-02 JP JP60171008A patent/JPS6143164A/ja active Granted
- 1985-08-02 NO NO853069A patent/NO166529C/no unknown
- 1985-08-02 ZA ZA855860A patent/ZA855860B/xx unknown
- 1985-08-02 PT PT80905A patent/PT80905B/pt not_active IP Right Cessation
- 1985-08-02 DK DK353785A patent/DK163661C/da not_active IP Right Cessation
- 1985-08-02 ES ES545870A patent/ES8703421A1/es not_active Expired
- 1985-08-02 FI FI852990A patent/FI80876C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0170281A2 (en) | 1986-02-05 |
| IL75985A (en) | 1988-07-31 |
| IL75985A0 (en) | 1985-12-31 |
| EP0170281A3 (en) | 1986-06-25 |
| ES8703421A1 (es) | 1987-02-16 |
| PT80905A (en) | 1985-09-01 |
| JPH0566942B2 (no) | 1993-09-22 |
| NO166529B (no) | 1991-04-29 |
| ES545870A0 (es) | 1987-02-16 |
| US4554353A (en) | 1985-11-19 |
| GR851890B (no) | 1985-12-09 |
| EP0170281B1 (en) | 1990-06-13 |
| DK353785D0 (da) | 1985-08-02 |
| AU4569385A (en) | 1986-02-06 |
| CA1270833A (en) | 1990-06-26 |
| DK163661C (da) | 1992-08-24 |
| CA1270833C (en) | 1990-06-26 |
| PT80905B (pt) | 1987-09-30 |
| ZA855860B (en) | 1986-10-29 |
| DK353785A (da) | 1986-02-04 |
| DE3578172D1 (de) | 1990-07-19 |
| PH20948A (en) | 1987-06-10 |
| IE60110B1 (en) | 1994-06-01 |
| IE851932L (en) | 1986-02-03 |
| JPS6143164A (ja) | 1986-03-01 |
| DK163661B (da) | 1992-03-23 |
| NO853069L (no) | 1986-02-04 |
| ATE53575T1 (de) | 1990-06-15 |
| FI80876B (fi) | 1990-04-30 |
| FI80876C (fi) | 1990-08-10 |
| FI852990A0 (fi) | 1985-08-02 |
| NZ212955A (en) | 1988-03-30 |
| FI852990L (fi) | 1986-02-04 |
| AU581914B2 (en) | 1989-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK129093A (en) | N-tert-butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl)isoquinoline-3-carboxamide & asparaginyl derivatives thereof | |
| NO163331C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer. | |
| DE3584608D1 (de) | Amidabkoemmlinge. | |
| AU581855B2 (en) | 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives | |
| NO167286C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater. | |
| NO169442C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser | |
| NO166529C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,5-pyrolidindion derivater. | |
| AU581856B2 (en) | 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives | |
| NO164243C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO171499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater | |
| FI894813A (fi) | Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi | |
| NO863005D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater. | |
| AU2013888A (en) | Uricosuric composition | |
| AU7748487A (en) | 2-amino-3-aroyl-omega-oxobenzenebutanoic acids and esters | |
| NO164657C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinoner. | |
| NO165798C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-disubstituerte 2-oksindol-derivater. | |
| YU47871B (sh) | Derivati aminokiselina |